Johnson & Johnson Other Nonoperating Income (Expense)
Johnson & Johnson (JNJ) reported Other Nonoperating Income (Expense) of -$331.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-07-23
- Johnson & Johnson other nonoperating income (expense) for the quarter ending 2026-06-28 was -$331.00M.
- Johnson & Johnson other nonoperating income (expense) for the quarter ending 2026-03-29 was -$294.00M, a 104.02% decline year-over-year.
- Johnson & Johnson other nonoperating income (expense) for the quarter ending 2025-12-28 was -$483.00M, a 400.00% decline year-over-year.
- Johnson & Johnson other nonoperating income (expense) for the quarter ending 2025-09-28 was $478.00M.
- Johnson & Johnson other nonoperating income (expense) for fiscal 2025 was $7.21B.
- Johnson & Johnson other nonoperating income (expense) for fiscal 2024 was -$4.69B.
- Johnson & Johnson other nonoperating income (expense) for fiscal 2023 was -$6.63B.
- Johnson & Johnson other nonoperating income (expense) for fiscal 2023 was -$810.00M.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | -$331.00M 10-Q · filed 2026-07-23 | -$625.00M 10-Q · filed 2026-07-23 | -$1.11B derived: sum of 3 quarters · filed 2026-07-23 | -$630.00M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2026-03-29 | -$294.00M 10-Q · filed 2026-04-22 | -$777.00M derived: sum of 2 quarters · filed 2026-04-22 | -$299.00M derived: sum of 3 quarters · filed 2026-04-22 | -$406.00M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-12-28 | -$483.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$5.00M derived: sum of 2 quarters · filed 2026-02-11 | -$112.00M derived: sum of 3 quarters · filed 2026-07-23 | $7.21B 10-K · filed 2026-02-11 | ||||
| 2025-09-28 | $478.00M 10-Q · filed 2025-10-22 | $371.00M derived: sum of 2 quarters · filed 2026-07-23 | $7.69B 10-Q · filed 2025-10-22 | $7.85B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-06-29 | -$107.00M 10-Q · filed 2026-07-23 | $7.21B 10-Q · filed 2026-07-23 | $7.38B derived: sum of 3 quarters · filed 2026-07-23 | $5.58B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-03-30 | $7.32B 10-Q · filed 2026-04-22 | $7.48B derived: sum of 2 quarters · filed 2026-04-22 | $5.68B derived: sum of 3 quarters · filed 2026-04-22 | $5.03B derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2024-12-29 | $161.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$1.64B derived: sum of 2 quarters · filed 2026-02-11 | -$2.29B derived: sum of 3 quarters · filed 2026-02-11 | -$4.69B 10-K · filed 2026-02-11 | ||||
| 2024-09-29 | -$1.80B 10-Q · filed 2025-10-22 | -$2.45B derived: sum of 2 quarters · filed 2025-10-22 | -$4.86B 10-Q · filed 2025-10-22 | -$4.43B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-06-30 | -$653.00M 10-Q · filed 2025-07-24 | -$3.06B 10-Q · filed 2025-07-24 | -$2.64B derived: sum of 3 quarters · filed 2026-02-11 | -$3.13B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-03-31 | -$2.40B 10-Q · filed 2025-04-23 | -$1.98B derived: sum of 2 quarters · filed 2026-02-11 | -$2.48B derived: sum of 3 quarters · filed 2026-02-11 | -$2.10B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2023-12-31 | $421.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$78.00M derived: sum of 2 quarters · filed 2026-02-11 | $306.00M derived: sum of 3 quarters · filed 2026-02-11 | -$6.63B 10-K · filed 2026-02-11 | ||||
| 2023-10-01 | -$499.00M 10-Q · filed 2024-10-23 | -$115.00M derived: sum of 2 quarters · filed 2024-10-23 | -$7.05B 10-Q · filed 2024-10-23 | -$7.85B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-07-02 | $384.00M 10-Q · filed 2024-07-25 | $60.00M 10-Q · filed 2023-07-31 | -$6.56B 10-Q · filed 2024-07-25 | -$7.17B 10-Q · filed 2023-07-31 | -$7.35B derived: sum of 3 quarters · filed 2025-02-13 | -$7.58B derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-04-02 | -$6.94B 10-Q · filed 2024-05-01 | -$7.23B 10-Q · filed 2023-04-28 | -$7.74B derived: sum of 2 quarters · filed 2025-02-13 | -$7.96B derived: sum of 3 quarters · filed 2025-02-13 | -$8.23B derived: sum of 4 quarters · filed 2025-02-13 | |||
| 2023-01-01 | -$795.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$1.02B derived: sum of 2 quarters · filed 2025-02-13 | -$1.29B derived: sum of 3 quarters · filed 2025-02-13 | -$810.00M 10-K · filed 2025-02-13 | -$1.87B 10-K · filed 2023-02-16 | |||
| 2022-10-02 | -$226.00M 10-Q · filed 2023-10-27 | -$493.00M 10-Q · filed 2022-10-27 | -$499.00M derived: sum of 2 quarters · filed 2023-10-27 | -$15.00M 10-Q · filed 2023-10-27 | -$664.00M 10-Q · filed 2022-10-27 | -$443.00M derived: sum of 4 quarters · filed 2024-02-16 | ||
| 2022-07-03 | -$273.00M 10-Q · filed 2023-07-31 | -$171.00M 10-Q · filed 2023-07-31 | -$217.00M derived: sum of 3 quarters · filed 2024-02-16 | -$2.07B derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-04-03 | $102.00M 10-Q · filed 2023-04-28 | $56.00M derived: sum of 2 quarters · filed 2024-02-16 | -$1.79B derived: sum of 3 quarters · filed 2024-02-16 | -$1.31B derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-01-02 | -$46.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | -$1.90B derived: sum of 2 quarters · filed 2024-02-16 | -$1.41B derived: sum of 3 quarters · filed 2024-02-16 | -$526.00M 10-K · filed 2024-02-16 | -$489.00M 10-K · filed 2022-02-17 | |||
| 2021-10-03 | -$1.85B 10-Q · filed 2022-10-27 | -$1.36B derived: sum of 2 quarters · filed 2022-10-27 | -$480.00M 10-Q · filed 2022-10-27 | -$2.83B derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-07-04 | $488.00M 10-Q · filed 2022-07-29 | $1.37B 10-Q · filed 2022-07-29 | -$984.00M derived: sum of 3 quarters · filed 2023-02-16 | -$2.18B derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-04-04 | $882.00M 10-Q · filed 2022-04-29 | -$1.47B derived: sum of 2 quarters · filed 2023-02-16 | -$2.67B derived: sum of 3 quarters · filed 2023-02-16 | -$2.70B derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-01-03 | -$2.35B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$3.55B derived: sum of 2 quarters · filed 2023-02-16 | -$3.58B derived: sum of 3 quarters · filed 2023-02-16 | -$2.90B 10-K · filed 2023-02-16 | ||||
| 2020-09-27 | -$1.20B 10-Q · filed 2021-10-29 | -$1.22B derived: sum of 2 quarters · filed 2021-10-29 | -$545.00M 10-Q · filed 2021-10-29 | -$561.00M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-06-28 | -$24.00M 10-Q · filed 2021-07-29 | $655.00M 10-Q · filed 2021-07-29 | $639.00M derived: sum of 3 quarters · filed 2022-02-17 | -$3.58B derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-03-29 | $679.00M 10-Q · filed 2021-04-30 | $663.00M derived: sum of 2 quarters · filed 2022-02-17 | -$3.55B derived: sum of 3 quarters · filed 2022-02-17 | -$1.87B derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2019-12-29 | -$16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | -$4.23B derived: sum of 2 quarters · filed 2022-02-17 | -$2.55B derived: sum of 3 quarters · filed 2022-02-17 | -$2.52B 10-K · filed 2022-02-17 | ||||
| 2019-09-29 | -$4.21B 10-Q · filed 2020-10-23 | -$2.53B derived: sum of 2 quarters · filed 2020-10-23 | -$2.51B 10-Q · filed 2020-10-23 | -$3.49B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-06-30 | $1.68B 10-Q · filed 2020-07-24 | $1.71B 10-Q · filed 2020-07-24 | $727.00M derived: sum of 3 quarters · filed 2021-02-22 | $724.00M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-03-31 | $22.00M 10-Q · filed 2020-04-29 | -$956.00M derived: sum of 2 quarters · filed 2021-02-22 | -$959.00M derived: sum of 3 quarters · filed 2021-02-22 | -$1.32B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2018-12-30 | -$978.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | -$981.00M derived: sum of 2 quarters · filed 2021-02-22 | -$1.34B derived: sum of 3 quarters · filed 2021-02-22 | -$1.41B 10-K · filed 2021-02-22 | ||||
| 2018-09-30 | -$3.00M 10-Q · filed 2019-10-28 | -$367.00M derived: sum of 2 quarters · filed 2019-10-28 | -$427.00M 10-Q · filed 2019-10-28 | -$374.00M derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-07-01 | -$364.00M 10-Q · filed 2019-07-29 | -$424.00M 10-Q · filed 2019-07-29 | -$371.00M derived: sum of 3 quarters · filed 2020-02-18 | -$74.00M derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-04-01 | -$60.00M 10-Q · filed 2019-05-01 | -$7.00M derived: sum of 2 quarters · filed 2020-02-18 | $290.00M derived: sum of 3 quarters · filed 2020-02-18 | -$237.00M derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2017-12-31 | $53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $350.00M derived: sum of 2 quarters · filed 2020-02-18 | -$177.00M derived: sum of 3 quarters · filed 2020-02-18 | $42.00M 10-K · filed 2020-02-18 | -$183.00M 10-K · filed 2018-02-21 | |||
| 2017-10-01 | $297.00M 10-Q · filed 2018-10-31 | $236.00M 10-Q · filed 2017-11-02 | -$230.00M derived: sum of 2 quarters · filed 2018-10-31 | -$11.00M 10-Q · filed 2018-10-31 | -$192.00M 10-Q · filed 2017-11-02 | $243.00M derived: sum of 4 quarters · filed 2019-02-20 | ||
| 2017-07-02 | -$527.00M 10-Q · filed 2018-08-02 | -$588.00M 10-Q · filed 2017-08-03 | -$308.00M 10-Q · filed 2018-08-02 | -$428.00M 10-Q · filed 2017-08-03 | -$54.00M derived: sum of 3 quarters · filed 2019-02-20 | $0.00 derived: sum of 4 quarters · filed 2019-02-20 | ||
| 2017-04-02 | $219.00M 10-Q · filed 2018-05-01 | $160.00M 10-Q · filed 2017-05-08 | $473.00M derived: sum of 2 quarters · filed 2019-02-20 | $527.00M derived: sum of 3 quarters · filed 2019-02-20 | -$30.00M derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-01-01 | $254.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $308.00M derived: sum of 2 quarters · filed 2019-02-20 | -$249.00M derived: sum of 3 quarters · filed 2019-02-20 | -$210.00M 10-K · filed 2019-02-20 | -$484.00M 10-K · filed 2017-02-27 | |||
| 2016-10-02 | $54.00M 10-Q · filed 2017-11-02 | -$503.00M derived: sum of 2 quarters · filed 2017-11-02 | -$464.00M 10-Q · filed 2017-11-02 | $741.00M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-07-03 | -$557.00M 10-Q · filed 2017-08-03 | -$518.00M 10-Q · filed 2017-08-03 | $687.00M derived: sum of 3 quarters · filed 2018-02-21 | $267.00M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-04-03 | $39.00M 10-Q · filed 2017-05-08 | $1.24B derived: sum of 2 quarters · filed 2018-02-21 | $824.00M derived: sum of 3 quarters · filed 2018-02-21 | $1.75B derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-01-03 | $1.21B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $785.00M derived: sum of 2 quarters · filed 2018-02-21 | $1.72B derived: sum of 3 quarters · filed 2018-02-21 | $2.06B 10-K · filed 2018-02-21 | ||||
| 2015-09-27 | -$420.00M 10-Q · filed 2016-11-04 | $511.00M derived: sum of 2 quarters · filed 2016-11-04 | $859.00M 10-Q · filed 2016-11-04 | -$104.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-28 | $931.00M 10-Q · filed 2016-08-04 | $1.28B 10-Q · filed 2016-08-04 | $316.00M derived: sum of 3 quarters · filed 2017-02-27 | $1.66B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-29 | $348.00M 10-Q · filed 2016-05-10 | -$615.00M derived: sum of 2 quarters · filed 2017-02-27 | $730.00M derived: sum of 3 quarters · filed 2017-02-27 | $504.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-28 | -$963.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $382.00M derived: sum of 2 quarters · filed 2017-02-27 | $156.00M derived: sum of 3 quarters · filed 2017-02-27 | $70.00M 10-K · filed 2017-02-27 | ||||
| 2014-09-28 | $1.34B 10-Q · filed 2015-10-30 | $1.12B derived: sum of 2 quarters · filed 2015-10-30 | $1.03B 10-Q · filed 2015-10-30 | $165.00M derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2014-06-29 | -$226.00M 10-Q · filed 2015-07-31 | -$312.00M 10-Q · filed 2015-07-31 | -$1.18B derived: sum of 3 quarters · filed 2016-02-24 | -$2.12B derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2014-03-30 | -$86.00M 10-Q · filed 2015-05-01 | -$954.00M derived: sum of 2 quarters · filed 2016-02-24 | -$1.90B derived: sum of 3 quarters · filed 2016-02-24 | -$2.07B derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2013-12-29 | -$868.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$1.81B derived: sum of 2 quarters · filed 2016-02-24 | -$1.98B derived: sum of 3 quarters · filed 2016-02-24 | -$2.50B 10-K · filed 2016-02-24 | ||||
| 2013-09-29 | -$943.00M 10-Q · filed 2014-10-30 | -$1.11B derived: sum of 2 quarters · filed 2014-10-30 | -$1.63B 10-Q · filed 2014-10-30 | -$1.95B derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | -$172.00M 10-Q · filed 2014-08-01 | -$687.00M 10-Q · filed 2014-08-01 | -$1.01B derived: sum of 3 quarters · filed 2015-02-24 | -$916.00M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | -$515.00M 10-Q · filed 2014-05-02 | -$834.00M derived: sum of 2 quarters · filed 2015-02-24 | -$744.00M derived: sum of 3 quarters · filed 2015-02-24 | -$2.75B derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-30 | -$319.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$229.00M derived: sum of 2 quarters · filed 2015-02-24 | -$2.24B derived: sum of 3 quarters · filed 2015-02-24 | -$1.63B 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $90.00M 10-Q · filed 2013-11-04 | -$1.92B derived: sum of 2 quarters · filed 2013-11-04 | -$1.31B 10-Q · filed 2013-11-04 | -$4.17B derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-07-01 | -$2.01B 10-Q · filed 2013-08-01 | -$1.40B 10-Q · filed 2013-08-01 | -$4.25B derived: sum of 3 quarters · filed 2014-02-21 | -$3.95B derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-04-01 | $611.00M 10-Q · filed 2013-05-03 | -$2.25B derived: sum of 2 quarters · filed 2014-02-21 | -$1.94B derived: sum of 3 quarters · filed 2014-02-21 | -$2.15B derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-01-01 | -$2.86B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | -$2.55B derived: sum of 2 quarters · filed 2014-02-21 | -$2.76B derived: sum of 3 quarters · filed 2014-02-21 | -$2.74B 10-K · filed 2014-02-21 | ||||
| 2011-10-02 | $308.00M 10-Q · filed 2012-11-09 | $102.00M derived: sum of 2 quarters · filed 2012-11-09 | $115.00M 10-Q · filed 2012-11-09 | -$985.00M derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2011-07-03 | -$206.00M 10-Q · filed 2012-08-02 | -$193.00M 10-Q · filed 2012-08-02 | -$1.29B derived: sum of 3 quarters · filed 2013-02-22 | -$1.00B derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2011-04-03 | $13.00M 10-Q · filed 2012-05-07 | -$1.09B derived: sum of 2 quarters · filed 2013-02-22 | -$795.00M derived: sum of 3 quarters · filed 2013-02-22 | -$813.00M derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2011-01-02 | -$1.10B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | -$808.00M derived: sum of 2 quarters · filed 2013-02-22 | -$826.00M derived: sum of 3 quarters · filed 2013-02-22 | $768.00M 10-K · filed 2013-02-22 | ||||
| 2010-10-03 | $292.00M 10-Q · filed 2011-11-08 | $274.00M derived: sum of 2 quarters · filed 2011-11-08 | $1.87B 10-Q · filed 2011-11-08 | $2.23B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-07-04 | -$18.00M 10-Q · filed 2011-08-09 | $18.00M 10-Q · filed 2010-08-11 | $1.58B 10-Q · filed 2011-08-09 | -$1.58B 10-Q · filed 2010-08-11 | $1.94B derived: sum of 3 quarters · filed 2012-02-23 | $2.03B derived: sum of 4 quarters · filed 2012-02-23 | ||
| 2010-04-04 | $1.59B 10-Q · filed 2011-05-10 | $1.96B derived: sum of 2 quarters · filed 2012-02-23 | $2.05B derived: sum of 3 quarters · filed 2012-02-23 | $2.06B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-01-03 | $361.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $457.00M derived: sum of 2 quarters · filed 2012-02-23 | $463.00M derived: sum of 3 quarters · filed 2012-02-23 | $526.00M 10-K · filed 2012-02-23 | ||||
| 2009-09-27 | $96.00M 10-Q · filed 2010-11-10 | $102.00M derived: sum of 2 quarters · filed 2010-11-10 | $165.00M 10-Q · filed 2010-11-10 | $815.00M derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2009-06-28 | $6.00M 10-Q · filed 2010-08-11 | -$6.00M 10-Q · filed 2009-08-04 | -$69.00M 10-Q · filed 2010-08-11 | $69.00M 10-Q · filed 2009-08-04 | $719.00M derived: sum of 3 quarters · filed 2011-02-25 | $943.00M derived: sum of 4 quarters · filed 2011-02-25 | ||
| 2009-03-29 | $75.00M 10-Q · filed 2010-05-10 | $713.00M derived: sum of 2 quarters · filed 2011-02-25 | $937.00M derived: sum of 3 quarters · filed 2011-02-25 | $1.07B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2008-12-28 | $638.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $862.00M derived: sum of 2 quarters · filed 2011-02-25 | $997.00M derived: sum of 3 quarters · filed 2011-02-25 | $1.01B 10-K · filed 2011-02-25 | ||||
| 2008-09-28 | $224.00M 10-Q · filed 2009-11-04 | $359.00M derived: sum of 2 quarters · filed 2009-11-04 | $377.00M 10-Q · filed 2009-11-04 | |||||
| 2008-06-29 | $135.00M 10-Q · filed 2009-08-04 | $153.00M 10-Q · filed 2009-08-04 | ||||||
| 2007-12-30 | -$534.00M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |